Symbyax^® combines olanzapine, an atypical antipsychotic and fluoxetine, a selective serotonin reuptake inhibitor. It is indicated for the acute treatment of depressive episodes associated with bipolar disorder in adults and for the treatment of treatment resistant depression.

Tegretol, carbamazepine USP, is an anticonvulsant and specific analgesic for trigeminal neuralgia. Tegretol is indicated for use as an anticonvulsant drug. This drug is not a simple analgesic and should not be used for the relief of trivial aches or pains.

Topamax^® (topiramate) is an antiepileptic agent indicated for the treatment of partial onset or primary generalized tonic-clonic seizures and for the prophylaxis of migraine headaches.

Providing a replacement for the 90s-vintage Goldberg bipolar test, this 19-question test uniquely highlights all three components which figure in the diagnosis of bipolar spectrum disorders, including depressive episodes and manic episodes (and mixed episodes), plus an additional set of factors which may preclude a diagnosis of bipolar disorder even when symptoms otherwise associated with bipolar are present.

Trileptal (oxcarbazepine) is an antiepileptic drug indicated for use as monotherapy or adjunctive therapy in the treatment of partial seizures in adults and as monotherapy in the treatment of partial seizures in children aged 4 years and above with epilepsy.

Zyprexa^® (olanzapine) is an atypical antipsychotic indicated for the treatment of schizophrenia and bipolar disorder and — in combination with fluoxetine — for the treatment of treatment resistant depression.